8-K
Current Report
Definium Therapeutics, Inc. Filed Acc 0000950170-22-001773
Shareholder rights changed
- Item 3.03 Material modification to rights of security holders
From the SEC's structured data for this filing
Loading mnmd-20220222.htm…